Anhui Anke Biotechnology (300009.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue...
Zhixin Finance APP News, Anhui Anke Biotechnology (300009.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue of 1.921 billion yuan, a decrease of 4.95% year-on-year. The net income attributable to the shareholders of the listed company was 0.59 billion yuan, a year-on-year decrease of 9.89%. The net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 0.555 billion yuan, a year-on-year decrease of 11.93%.